InsiderClue
Stocks · Health care · Pharmaceutical Preparations

XORTX Therapeutics Inc.

XRTX Clue Score34
British Columbia, Canada Fiscal year ends December CIK 0001729214
$1.72 +21.99% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.72 −63.93% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 28 Nov 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Net income
Fiscal year 2019Net income−0.6Fiscal year 2020Net income−1.3Fiscal year 2021Net income−1.7
FY2019FY2020FY2021
Net income −0.6 −1.3 −1.7
Growth

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2019Operating cash flow−0.2Fiscal year 2020Operating cash flow−0.7Fiscal year 2021Operating cash flow−6.1
FY2019FY2020FY2021
Operating cash flow −0.2 −0.7 −6.1

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash and securities
Fiscal year 2019Cash and securities0.1Shareholders’ equity−0.2Fiscal year 2020Cash and securities0.2Shareholders’ equity1.3Fiscal year 2021Cash and securities18.9Shareholders’ equity16.7
FY2019FY2020FY2021
Cash and securities 0.1 0.2 18.9
Shareholders’ equity −0.2 1.3 16.7

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2021 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021
Operations
−0.2 −0.7 −6.1
Growth
0.0 0.0 0.0
Financing
0.1 0.9 24.5

Capital expenditure, dividends and buybacks are shown as money out, so negative.